Clinical Trial Update: Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating total neoadjuvant induction and consolidation CapeOX plus IMRT with capecitabine for MRI-defined high-risk rectal cancer; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• CAPEOX
• Capecitabine (capecitabine)
• IMRT

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED